NEBIVOLOL 5mg. IP

A beta-blocker is used to treat high blood pressure and heart failure. An advantageous treatment for essential hypertension, ischemic heart disease, and congestive heart failure. (M Mangrella, 1998) An attractive addition to the antihypertensive repertoire. (L Van Nueten, 1997) Demonstrates sustained effects in lowering both systolic and diastolic pressures. (L Van Nueten M. R., 1999) A well-tolerated agent for patients with hypertension and heart failure. (Rudolf A de Boer, 2007) Has a good antihypertensive effect in supine as well as in standing position. (L M Van Bortel, 1993) Effectively diminishes cardiovascular morbidity and mortality in elderly patients with heart failure. (John, 2007) An effective antihypertensive agent has a superior tolerability profile as compared to other antihypertensive agents. (John, 2007) Appears potentially valuable for the treatment of hypertension. (L Van Nueten F. R., 1998) Shows a better tolerability profile than atenolol and a lower incidence of adverse effects. (Guido Grassi, 2003) Ten times more potent than atenolol in the treatment of essential hypertension. (G Simon, 1993) An alternative first-line treatment option for the management of patients with mild to moderate uncomplicated essential hypertension. (W McNeely, 1999) A safe and effective antihypertensive medicament that provides long-term BP-lowering effects. (Papademetriou, 2009) Significantly more effective than nifedipine in patients with essential hypertension. (L Van Nueten Y. L., 1998)